- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 114-128 of
161 results
1011 Exhibit: EX1011 US Patnt No 5,656,286 to Miranda
Document
IPR2018-00174, No. 1011 Exhibit - EX1011 US Patnt No 5,656,286 to Miranda (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
1026 Exhibit: EX1026 Bronaugh
Document
IPR2018-00174, No. 1026 Exhibit - EX1026 Bronaugh (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
1010 Exhibit: EX1010 Kim
Document
IPR2018-00174, No. 1010 Exhibit - EX1010 Kim (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
2009 Exhibit: Esclim Product Label
Document
IPR2018-00174, No. 2009 Exhibit - Esclim Product Label (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
1005 Exhibit: EX1005 US Pat Pub 20030099695 to Mueller
Document
IPR2018-00174, No. 1005 Exhibit - EX1005 US Pat Pub 20030099695 to Mueller (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
2011 Exhibit: A Williams B Barry, Chemical Permeation Enhancement
Document
IPR2018-00174, No. 2011 Exhibit - A Williams B Barry, Chemical Permeation Enhancement (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2014 Exhibit: Google Scholar search results obtained March 7, 2018, citations of K...
Document
IPR2018-00174, No. 2014 Exhibit - Google Scholar search results obtained March 7, 2018, citations of Kim et al, Penetration Enhancement of B2 Selective Agonist, Tulobuterol, Across Hairless ...
|
|
Cite Document
2005 Exhibit: J Hadgraft, Passive enhancement strategies in topical and transderm...
Document
IPR2018-00174, No. 2005 Exhibit - J Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2018 Exhibit: R Hinz et al, In vitro percutaneous penetration evaluation of the utility...
Document
IPR2018-00174, No. 2018 Exhibit - R Hinz et al, In vitro percutaneous penetration evaluation of the utility of hairless mouse skin (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2004 Exhibit: J Hadgraft and R Guy, Feasibility Assessment in Topical and Transde...
Document
IPR2018-00174, No. 2004 Exhibit - J Hadgraft and R Guy, Feasibility Assessment in Topical and Transdermal Delivery (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2019 Exhibit: J Bond B Barry, Hairless mouse skin is limited as a model for assessin...
Document
IPR2018-00174, No. 2019 Exhibit - J Bond B Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
1023 Exhibit: EX1023 Dinger Noven Pharmaceuticals, Inc
Document
IPR2018-00174, No. 1023 Exhibit - EX1023 Dinger Noven Pharmaceuticals, Inc (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
1001 Exhibit: EX1001 US 9,730,900 to Mantelle
Document
IPR2018-00174, No. 1001 Exhibit - EX1001 US 9,730,900 to Mantelle (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
2017 Exhibit: B Godin E Touitou, Transdermal skin delivery Predictions for humans...
Document
IPR2018-00174, No. 2017 Exhibit - B Godin E Touitou, Transdermal skin delivery Predictions for humans from in vivo, ex vivo and animal models (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
1028 Exhibit: EX1028 US Patent No 5,603,947 to Wong
Document
IPR2018-00174, No. 1028 Exhibit - EX1028 US Patent No 5,603,947 to Wong (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
